Bodick Neil 4
4 · Flexion Therapeutics Inc · Filed Jan 4, 2019
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-01-03$12.36/sh−746$9,221→ 64,782 total
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Sale of shares of common stock pursuant to Rule 10b5-1 arrangements to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2018.
- [F2]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.